Your browser doesn't support javascript.
loading
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer.
Schlumberger, Martin; Jarzab, Barbara; Cabanillas, Maria E; Robinson, Bruce; Pacini, Furio; Ball, Douglas W; McCaffrey, Judith; Newbold, Kate; Allison, Roger; Martins, Renato G; Licitra, Lisa F; Shah, Manisha H; Bodenner, Donald; Elisei, Rossella; Burmeister, Lynn; Funahashi, Yasuhiro; Ren, Min; O'Brien, James P; Sherman, Steven I.
Afiliação
  • Schlumberger M; Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave-Roussy and University Paris-Sud, Villejuif, France. martin.schlumberger@gustaveroussy.fr.
  • Jarzab B; Department of Nuclear Medicine and Endocrine Oncology, Centrum Onkologii Instytut im. M. Sklodowskiei-Curie, Gliwice, Poland.
  • Cabanillas ME; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Robinson B; Department of Endocrinology, Royal North Shore Hospital, Sydney, Australia.
  • Pacini F; Department of Medical, Surgical and Neurological Sciences, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
  • Ball DW; Division of Endocrinology and Metabolism, Johns Hopkins Medical Institute, Baltimore, Maryland.
  • McCaffrey J; Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Newbold K; NIHR Royal Marsden Hospital and Institute of Cancer Research BRC, London, UK.
  • Allison R; Cancer Care Services, The Royal Brisbane and Women's Hospital, Herston, Australia.
  • Martins RG; Division of Clinical Research, Seattle Cancer Care Alliance, Seattle, Washington.
  • Licitra LF; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Shah MH; Department of Medical Oncology, The Ohio State University School of Medicine, Columbus, Ohio.
  • Bodenner D; Department of Otolaryngology-Head and Neck Surgery, University of Arkansas, Little Rock, Arkansas.
  • Elisei R; Endocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Burmeister L; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Funahashi Y; Eisai, Andover, Massachusetts.
  • Ren M; Eisai Inc., Woodcliff Lake, New Jersey.
  • O'Brien JP; Eisai Inc., Woodcliff Lake, New Jersey.
  • Sherman SI; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 22(1): 44-53, 2016 Jan 01.
Article em En | MEDLINE | ID: mdl-26311725
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Neoplasias da Glândula Tireoide / Carcinoma Neuroendócrino / Inibidores de Proteínas Quinases / Terapia de Alvo Molecular / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Neoplasias da Glândula Tireoide / Carcinoma Neuroendócrino / Inibidores de Proteínas Quinases / Terapia de Alvo Molecular / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article